Byars NE and Allison AC |
Adjuvant formulation for use in vaccines to elicit both cell-mediated and humoral immunity. |
1987 |
Vaccine |
pmid:3499713
|
Higgins DA et al. |
MF59 adjuvant enhances the immunogenicity of influenza vaccine in both young and old mice. |
1996 |
Vaccine |
pmid:8782343
|
Cataldo DM and Van Nest G |
The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice. |
1997 |
Vaccine |
pmid:9364672
|
Singh M et al. |
A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2. |
1998 |
Vaccine |
pmid:9795387
|
Barchfeld GL et al. |
The adjuvants MF59 and LT-K63 enhance the mucosal and systemic immunogenicity of subunit influenza vaccine administered intranasally in mice. |
1999 |
Vaccine |
pmid:10067675
|
Hilgers LA et al. |
Sulfolipo-cyclodextrin in squalane-in-water as a novel and safe vaccine adjuvant. |
1999 |
Vaccine |
pmid:9987157
|
Podda A |
The adjuvanted influenza vaccines with novel adjuvants: experience with the MF59-adjuvanted vaccine. |
2001 |
Vaccine |
pmid:11257408
|
Greer CE et al. |
The comparison of the effect of LTR72 and MF59 adjuvants on mouse humoral response to intranasal immunisation with human papillomavirus type 6b (HPV-6b) virus-like particles. |
2000 |
Vaccine |
pmid:11137233
|
Skeiky YA et al. |
Protective efficacy of a tandemly linked, multi-subunit recombinant leishmanial vaccine (Leish-111f) formulated in MPL adjuvant. |
2002 |
Vaccine |
pmid:12213399
|
Madhun AS et al. |
An adjuvanted pandemic influenza H1N1 vaccine provides early and long term protection in health care workers. |
2010 |
Vaccine |
pmid:21034828
|
Esposito S et al. |
Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major. |
2010 |
Vaccine |
pmid:20888873
|
Tritto E et al. |
Mechanism of action of licensed vaccine adjuvants. |
2009 |
Vaccine |
pmid:19200813
|
Ansaldi F et al. |
Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection. |
2009 |
Vaccine |
pmid:19200846
|
Camilloni B et al. |
Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. |
2009 |
Vaccine |
pmid:19410623
|
Phillips CJ et al. |
Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. |
2009 |
Vaccine |
pmid:19379786
|
Carmona A et al. |
Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. |
2010 |
Vaccine |
pmid:20600478
|
Frey SE et al. |
Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. |
2010 |
Vaccine |
pmid:20619382
|
Dell'Era L et al. |
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis. |
2012 |
Vaccine |
pmid:22138210
|
Okike IO et al. |
The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. |
2011 |
Vaccine |
pmid:21742005
|
Guillon C et al. |
Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits. |
2007 |
Vaccine |
pmid:17904700
|
Baldo V et al. |
MF59-adjuvanted influenza vaccine confers superior immunogenicity in adult subjects (18-60 years of age) with chronic diseases who are at risk of post-influenza complications. |
2007 |
Vaccine |
pmid:17383057
|
Bråve A et al. |
Candidate HIV-1 gp140DeltaV2, Gag and Tat vaccines protect against experimental HIV-1/MuLV challenge. |
2007 |
Vaccine |
pmid:17707956
|
Ansaldi F et al. |
Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses. |
2008 |
Vaccine |
pmid:18294741
|
O'Hagan DT et al. |
Cationic microparticles are a potent delivery system for a HCV DNA vaccine. |
2004 |
Vaccine |
pmid:15542189
|
Faenzi E et al. |
One dose of an MF59-adjuvanted pandemic A/H1N1 vaccine recruits pre-existing immune memory and induces the rapid rise of neutralizing antibodies. |
2012 |
Vaccine |
pmid:22521851
|
Hatz C et al. |
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations. |
2012 |
Vaccine |
pmid:22626675
|
Dey AK et al. |
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein. |
2012 |
Vaccine |
pmid:22366638
|
Reynales H et al. |
A prospective observational safety study on MF59(®) adjuvanted cell culture-derived vaccine, Celtura(®) during the A/H1N1 (2009) influenza pandemic. |
2012 |
Vaccine |
pmid:22902681
|
Yang WH et al. |
Long-term immunogenicity of an AS03-adjuvanted influenza A(H1N1)pdm09 vaccine in young and elderly adults: an observer-blind, randomized trial. |
2013 |
Vaccine |
pmid:23856331
|
Calabro S et al. |
The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect. |
2013 |
Vaccine |
pmid:23684834
|
Segura-Velázquez R et al. |
Influenza vaccine: development of a novel intranasal and subcutaneous recombinant adjuvant. |
2013 |
Vaccine |
pmid:23746458
|
Puig-Barberà J et al. |
MF59-adjuvanted and virosomal influenza vaccines for preventing influenza hospitalization in older people: comparative effectiveness using the Valencia health care information system. |
2013 |
Vaccine |
pmid:23731629
|
Rouleau I et al. |
Increased risk of anaphylaxis following administration of 2009 AS03-adjuvanted monovalent pandemic A/H1N1 (H1N1pdm09) vaccine. |
2013 |
Vaccine |
pmid:24144473
|
Vinay TN et al. |
Toxicity and dose determination of quillaja saponin, aluminum hydroxide and squalene in olive flounder (Paralichthys olivaceus). |
2014 |
Vet. Immunol. Immunopathol. |
pmid:23570990
|
Drulak MW et al. |
Vaccination of seropositive subjects with CHIRON CMV gB subunit vaccine combined with MF59 adjuvant for production of CMV immune globulin. |
2000 |
Viral Immunol. |
pmid:10733168
|
Marshall BC and Adler SP |
Avidity maturation following immunization with two human cytomegalovirus (CMV) vaccines: a live attenuated vaccine (Towne) and a recombinant glycoprotein vaccine (gB/MF59). |
2003 |
Viral Immunol. |
pmid:14733736
|
Heinemann L et al. |
Effective induction of type 1 helper IgG2a and cytotoxic T-cell responses in mice following immunization with human papillomavirus type 16 E2 in MF59. |
2008 |
Viral Immunol. |
pmid:18476769
|
Burke B et al. |
Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits. |
2009 |
Virology |
pmid:19249806
|
Stephenson I et al. |
Detection of anti-H5 responses in human sera by HI using horse erythrocytes following MF59-adjuvanted influenza A/Duck/Singapore/97 vaccine. |
2004 |
Virus Res. |
pmid:15163495
|
Clouse SD |
Brassinosteroids. Plant counterparts to animal steroid hormones? |
2002 |
Vitam. Horm. |
pmid:12481548
|
Zadák Z et al. |
[The role of cholesterol and intermediary metabolites of its synthesis in intensive care and parenteral nutrition]. |
2000 |
Vnitr Lek |
pmid:15637893
|
PokrovskiÄ AA et al. |
[Method of isolating, identifying and quantitatively determining alkanes, cycloalkanes, monocyclic arenes and squalene in animal organs and tissues]. |
1978 Sep-Oct |
Vopr Pitan |
pmid:716335
|
Markelova VF and Levachev MM |
[Inclusion of C14-acetate in cholesterol and tissue squalene of rats in choline-protein deficiency]. |
1967 Nov-Dec |
Vopr Pitan |
pmid:5610866
|
Gonor KV et al. |
[The influence of a diet with including amaranth oil on antioxidant and immune status in patients with ischemic heart disease and hyperlipoproteidemia]. |
2006 |
Vopr Pitan |
pmid:17313043
|
Gonor KV et al. |
[The influence of diet with including amaranth oil on lipid metabolism in patients with ischemic heart disease and hyperlipoproteidemia]. |
2006 |
Vopr Pitan |
pmid:16862949
|
Kulakova SN et al. |
[Amaranths oil: peculiarities of chemical composition and influence on lipid metabolism by rats]. |
2006 |
Vopr Pitan |
pmid:16862953
|
Palamarchuk VI et al. |
[Content of squalene and sterols in tissues of the hemopoietic system in normal rats and in experimental leukemia]. |
1983 May-Jun |
Vopr. Med. Khim. |
pmid:6880121
|
Kozlov VG and Viktorova EG |
[Evaluation of the efficiency and reactogenicity of emulsion-based adjuvant systems in the manufacture of polyclonal enteroviral diagnostic sera]. |
2011 Mar-Apr |
Vopr. Virusol. |
pmid:21545042
|
Zhao M et al. |
[Research progress on the squalene synthase]. |
2003 |
Wei Sheng Wu Xue Bao |
pmid:16281569
|
Lynen F |
[The biochemical basis of the biosynthesis of cholesterol and fatty acids]. |
1966 |
Wien. Klin. Wochenschr. |
pmid:4296920
|
Bakalar B et al. |
Changes in cholesterol and its precursors during the first days after major trauma. |
2003 |
Wien. Klin. Wochenschr. |
pmid:14743581
|
|
Global Advisory Committee on Vaccine Safety, 6-7 June 2006. |
2006 |
Wkly. Epidemiol. Rec. |
pmid:16841398
|
Richter E et al. |
Stimulation of the faecal excretion of 2,4,5,2',4',5'-hexachlorobiphenyl in rats by squalane. |
1983 |
Xenobiotica |
pmid:6415933
|
Hu JJ et al. |
[Antibody production and its neutralization of Abeta42's cytoxicity in BALB/c mice induced by Abeta42 and its subunit vaccines]. |
2004 |
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi |
pmid:15191720
|
Ikekawa T et al. |
[Studies on antitumor activity of squalene and its related compounds]. |
1986 |
Yakugaku Zasshi |
pmid:3772729
|
Tsai TF |
MF59 adjuvanted seasonal and pandemic influenza vaccines. |
2011 |
Yakugaku Zasshi |
pmid:22129867
|
Abe I |
[Engineering of squalene cyclizing enzymes]. |
2008 |
Yakugaku Zasshi |
pmid:18670176
|
Zhang Y et al. |
[Chemical constituents from the mangrove plant Ceriops tagal]. |
2005 |
Yao Xue Xue Bao |
pmid:16408813
|
Sondergaard E et al. |
Alimentary production of gallstones in hamsters. 28. Influence of isomerized squalene on gallstone production. |
1974 |
Z Ernahrungswiss |
pmid:4450595
|
Dam H et al. |
Alimentary production of gallstones in hamsters. 27. Influence of supplementation of the gallstone producing diet with squalene, cholesterol, certain other sterols, fish oil fatty acid ethyl esters, and modification of the basal diet on gallstone production and levels of cholesterol in serum and liver. |
1974 |
Z Ernahrungswiss |
pmid:4615449
|
Kipping D |
[Observations on skin surface fats]. |
1965 |
Z Haut Geschlechtskr |
pmid:5860995
|
Gloor M |
[The significance of physiological and biochemical deviations from the norm on the skin surface for infectious skin diseases (proceedings)]. |
1976 |
Z. Hautkr. |
pmid:13544
|
de la Puerta R et al. |
Effect of minor components of virgin olive oil on topical antiinflammatory assays. |
2000 Sep-Oct |
Z. Naturforsch., C, J. Biosci. |
pmid:11098836
|
Kopena R et al. |
Lipophilic compounds from the femoral gland secretions of male Hungarian green lizards, Lacerta viridis. |
2009 May-Jun |
Z. Naturforsch., C, J. Biosci. |
pmid:19678551
|
Liu Y et al. |
[Researches on influence of squalene synthase gene polymorphism on catalytic efficiency of its encode enzyme in Glycyrrhiza uralensis]. |
2012 |
Zhongguo Zhong Yao Za Zhi |
pmid:23627178
|
Li RC et al. |
[Study on the safety and immunogenicity of MF59-adjuvanted influenza subunit vaccine in Chinese elderly]. |
2008 |
Zhonghua Liu Xing Bing Xue Za Zhi |
pmid:19040034
|